Found: 82
Select item for more details and to access through your institution.
Integrative Tumor Board: Metastatic Renal Cell Carcinoma.
- Published in:
- Integrative Cancer Therapies, 2004, v. 3, n. 1, p. 29, doi. 10.1177/1534735404262986
- By:
- Publication type:
- Article
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1419, doi. 10.1007/s00262-011-1028-0
- By:
- Publication type:
- Article
Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 4, p. 323, doi. 10.1007/s00262-003-0452-1
- By:
- Publication type:
- Article
Immunotherapeutic potential of whole tumour cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 7, p. 351, doi. 10.1007/s00262-002-0286-2
- By:
- Publication type:
- Article
Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib.
- Published in:
- BJU International, 2021, v. 128, n. 2, p. 254, doi. 10.1111/bju.15356
- By:
- Publication type:
- Article
A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer.
- Published in:
- BJU International, 2019, v. 124, n. 4, p. 609, doi. 10.1111/bju.14811
- By:
- Publication type:
- Article
Engrailed homeobox transcription factors as potential markers and targets in cancer
- Published in:
- FEBS Letters, 2013, v. 587, n. 6, p. 549, doi. 10.1016/j.febslet.2013.01.054
- By:
- Publication type:
- Article
A phase 1 trial of human telomerase reverse transcriptase (hTERT) vaccination combined with therapeutic strategies to control immune-suppressor mechanisms.
- Published in:
- Experimental Biology & Medicine, 2024, p. 1, doi. 10.3389/ebm.2024.10021
- By:
- Publication type:
- Article
Induction of trismus by sunitinib and pazopanib in metastatic renal cell carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Basaloid carcinoma of the prostate: A literature review with case report.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER Stress.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 5, p. 931, doi. 10.1038/mt.2015.15
- By:
- Publication type:
- Article
Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory Agents.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 5, p. 845, doi. 10.1038/mt.2014.253
- By:
- Publication type:
- Article
The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 11, p. 1936, doi. 10.1038/mt.2014.134
- By:
- Publication type:
- Article
Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 10, p. 1851, doi. 10.1038/mt.2014.118
- By:
- Publication type:
- Article
Functional Cloning of Recurrence-specific Antigens Identifies Molecular Targets to Treat Tumor Relapse.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 8, p. 1507, doi. 10.1038/mt.2013.116
- By:
- Publication type:
- Article
Membrane insertion and secretion of the Engrailed-2 (EN2) transcription factor by prostate cancer cells may induce antiviral activity in the stroma.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-41678-0
- By:
- Publication type:
- Article
Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 425, p. 1, doi. 10.1126/scitranslmed.aar2041
- By:
- Publication type:
- Article
Front Cover: Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI‐001 in in vitro Models of Prostate Cancer Drug Resistance (ChemMedChem 2/2023).
- Published in:
- ChemMedChem, 2023, v. 18, n. 2, p. 1, doi. 10.1002/cmdc.202200703
- By:
- Publication type:
- Article
Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI‐001 in in vitro Models of Prostate Cancer Drug Resistance.
- Published in:
- ChemMedChem, 2023, v. 18, n. 2, p. 1, doi. 10.1002/cmdc.202200548
- By:
- Publication type:
- Article
Calcium insensitivity of FA-6, a cell line derived from a pancreatic cancer associated with humoral hypercalcemia, is mediated by the significantly reduced expression of the Calcium Sensitive Receptor transduction component p38 MAPK.
- Published in:
- Molecular Cancer, 2006, v. 5, p. 51, doi. 10.1186/1476-4598-5-51
- By:
- Publication type:
- Article
E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: Correlation with histopathological grade, tumour stage and survival.
- Published in:
- International Journal of Cancer, 1995, v. 64, n. 6, p. 367, doi. 10.1002/ijc.2910640603
- By:
- Publication type:
- Article
Live viruses to treat cancer.
- Published in:
- Journal of the Royal Society of Medicine, 2013, v. 106, n. 8, p. 310, doi. 10.1177/0141076813494196
- By:
- Publication type:
- Article
Differential effects of Paclitaxel on dendritic cell function.
- Published in:
- BMC Immunology, 2010, v. 11, p. 14, doi. 10.1186/1471-2172-11-14
- By:
- Publication type:
- Article
Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Precise Scheduling of Chemotherapy Primes VEGF-producing Tumors for Successful Systemic Oncolytic Virotherapy.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 10, p. 1802, doi. 10.1038/mt.2011.147
- By:
- Publication type:
- Article
The Effect of Cell Cycle Synchronization on Tumor Sensitivity to Reovirus Oncolysis.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 12, p. 2085, doi. 10.1038/mt.2010.189
- By:
- Publication type:
- Article
Therapeutic Effect of Sodium Iodide Symporter Gene Therapy Combined With External Beam Radiotherapy and Targeted Drugs That Inhibit DNA Repair.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 9, p. 1599, doi. 10.1038/mt.2010.120
- By:
- Publication type:
- Article
5th International Meeting on Replicating Oncolytic Virus Therapeutics Banff, Alberta, Canada, 18–22 March 2009.
- Published in:
- 2009
- By:
- Publication type:
- Proceeding
Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 4, p. 337, doi. 10.1038/nbt.2157
- By:
- Publication type:
- Article
The evolutionarily conserved long non‐coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 7, p. 1921, doi. 10.1002/1878-0261.12954
- By:
- Publication type:
- Article
Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression.
- Published in:
- Molecular Oncology, 2016, v. 10, n. 5, p. 693, doi. 10.1016/j.molonc.2015.12.010
- By:
- Publication type:
- Article
Immunotherapy of murine prostate cancer using whole tumor cells killed ex vivo by herpes simplex viral thymidine kinase/ganciclovir suicide gene therapy.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 6, p. 572, doi. 10.1038/sj.cgt.7700836
- By:
- Publication type:
- Article
Multiplatform Biomarker Discovery for Bladder Cancer Recurrence Diagnosis.
- Published in:
- Disease Markers, 2016, p. 1, doi. 10.1155/2016/4591910
- By:
- Publication type:
- Article
A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1129140
- By:
- Publication type:
- Article
Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22115-1
- By:
- Publication type:
- Article
Genetic and immune landscape evolution in MMR‐deficient colorectal cancer.
- Published in:
- Journal of Pathology, 2024, v. 262, n. 2, p. 226, doi. 10.1002/path.6228
- By:
- Publication type:
- Article
Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer.
- Published in:
- BJU International, 2012, v. 110, n. 6b, p. E287, doi. 10.1111/j.1464-410X.2012.11208.x
- By:
- Publication type:
- Article
The feasibility of establishing a programme of adjuvant autologous vaccination for renal cell carcinoma.
- Published in:
- BJU International, 2009, v. 103, n. 6, p. 740, doi. 10.1111/j.1464-410X.2008.08113.x
- By:
- Publication type:
- Article
A novel murine model of allogeneic vaccination against renal cancer.
- Published in:
- BJU International, 2008, v. 101, n. 9, p. 1165, doi. 10.1111/j.1464-410X.2008.07532.x
- By:
- Publication type:
- Article
Prognostic significance of erythropoietin expression in human renal cell carcinoma.
- Published in:
- BJU International, 2007, v. 100, n. 2, p. 291, doi. 10.1111/j.1464-410X.2007.06978.x
- By:
- Publication type:
- Article
Immunotherapy of murine prostate cancer using whole tumour cells killed ex vivo by cytosine deaminase/5-fluorocytosine suicide-gene therapy.
- Published in:
- BJU International, 2005, v. 95, n. 9, p. 1336, doi. 10.1111/j.1464-410X.2005.05528.x
- By:
- Publication type:
- Article
Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II study.
- Published in:
- BJU International, 2004, v. 94, n. 3, p. 412, doi. 10.1111/j.1464-410X.2004.04922.x
- By:
- Publication type:
- Article
Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances.
- Published in:
- Oncolytic Virotherapy, 2016, v. 5, p. 1, doi. 10.2147/OV.S66083
- By:
- Publication type:
- Article
Applications of coxsackievirus A21 in oncology.
- Published in:
- Oncolytic Virotherapy, 2014, v. 3, p. 47, doi. 10.2147/OV.S56322
- By:
- Publication type:
- Article
Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33555-8
- By:
- Publication type:
- Article
Cell Carriage, Delivery, and Selective Replication of an Oncolytic Virus in Tumor in Patients.
- Published in:
- Science Translational Medicine, 2012, v. 4, n. 138, p. 1, doi. 10.1126/scitranslmed.3003578
- By:
- Publication type:
- Article
Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression.
- Published in:
- Pigment Cell & Melanoma Research, 2013, v. 26, n. 2, p. 226, doi. 10.1111/pcmr.12060
- By:
- Publication type:
- Article
Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Modifying the Non-muscle Invasive Bladder Cancer Immune Microenvironment for Optimal Therapeutic Response.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00175
- By:
- Publication type:
- Article
A Specific Blood Signature Reveals Higher Levels of S100A12: A Potential Bladder Cancer Diagnostic Biomarker Along With Urinary Engrailed-2 Protein Detection.
- Published in:
- Frontiers in Oncology, 2020, v. 9, p. 1, doi. 10.3389/fonc.2019.01484
- By:
- Publication type:
- Article